US obesity rates drop for 1st time in a decade, with possible help from weight loss medications
Obesity rates in the U.S. showed a slight decline from 46% to 45.6%, marking the first decrease in over a decade.
Science in 2025: the events to watch for next year
Emerging obesity treatments like orforglipron and retatrutide show significant potential, possibly transforming the landscape of weight loss drugs in 2025.
Elon Musk dubs himself "Ozempic Santa" as weight loss drugs go mainstream
Elon Musk's use of an anti-obesity drug signals a shift towards mainstream acceptance and discussion of weight-loss medications.
Weight-loss drugs could be key in lowering US obesity rates experts
Weight-loss drugs like GLP-1 agonists may play an essential role in reducing obesity rates and improving overall health outcomes in the US.
3 GLP-1 Stocks to Buy Now For Big Long-Term Gains
Weight loss drug market shows impressive growth, driven by GLP-1 agonists.
New potential applications for these drugs could significantly expand the market.
Positive investor sentiment around biotech companies focused on weight loss drugs.
Could Ozempic treat addiction?
GLP-1 receptor agonists may reduce cravings not just for food but also for drugs and alcohol, aiding recovery from addiction.
US obesity rates drop for 1st time in a decade, with possible help from weight loss medications
Obesity rates in the U.S. showed a slight decline from 46% to 45.6%, marking the first decrease in over a decade.
Science in 2025: the events to watch for next year
Emerging obesity treatments like orforglipron and retatrutide show significant potential, possibly transforming the landscape of weight loss drugs in 2025.
Elon Musk dubs himself "Ozempic Santa" as weight loss drugs go mainstream
Elon Musk's use of an anti-obesity drug signals a shift towards mainstream acceptance and discussion of weight-loss medications.
Weight-loss drugs could be key in lowering US obesity rates experts
Weight-loss drugs like GLP-1 agonists may play an essential role in reducing obesity rates and improving overall health outcomes in the US.
3 GLP-1 Stocks to Buy Now For Big Long-Term Gains
Weight loss drug market shows impressive growth, driven by GLP-1 agonists.
New potential applications for these drugs could significantly expand the market.
Positive investor sentiment around biotech companies focused on weight loss drugs.
Could Ozempic treat addiction?
GLP-1 receptor agonists may reduce cravings not just for food but also for drugs and alcohol, aiding recovery from addiction.
How 'miracle' weight-loss drugs will change the world
GLP-1 agonists could lead to a healthier society by reducing obesity and related health issues by 2030.
Is Ozempic an Obesity Drug, or an Everything Drug?
The weekly shots, such as GLP-1 agonists, used for weight loss can have various health benefits beyond shedding pounds.
Are Weight-Loss Drugs Causing a Rift in Your Relationship? We Want to Hear About It.
Drastic physical changes in a partner can significantly impact romantic relationships, altering dynamics of intimacy, self-image, and emotional responses.
What To Do If Your Teen Asks To Go On Ozempic, According To Doctors
The popularity of Ozempic reflects societal obsessions with weight loss, impacting conversations around body image and health, especially for younger generations.
GLP-1 Agonists May Help Treatment of Mental Illness and Substance Use
GLP-1 agonists, like semaglutide, are effective for weight loss but their high prices hinder accessibility and public health benefits.
The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side Effects
GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects.
How 'miracle' weight-loss drugs will change the world
GLP-1 agonists could lead to a healthier society by reducing obesity and related health issues by 2030.
Is Ozempic an Obesity Drug, or an Everything Drug?
The weekly shots, such as GLP-1 agonists, used for weight loss can have various health benefits beyond shedding pounds.
Are Weight-Loss Drugs Causing a Rift in Your Relationship? We Want to Hear About It.
Drastic physical changes in a partner can significantly impact romantic relationships, altering dynamics of intimacy, self-image, and emotional responses.
What To Do If Your Teen Asks To Go On Ozempic, According To Doctors
The popularity of Ozempic reflects societal obsessions with weight loss, impacting conversations around body image and health, especially for younger generations.
GLP-1 Agonists May Help Treatment of Mental Illness and Substance Use
GLP-1 agonists, like semaglutide, are effective for weight loss but their high prices hinder accessibility and public health benefits.
The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side Effects
GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects.
Daily briefing: No one knows how smell really works - scientists are sniffing out the answers
GLP-1 agonists show varying effectiveness, influencing treatment choices based on individual patient conditions.
What's the best way to lose weight, following a diet or taking drugs like Ozempic?
The importance of combating the social stigma around obesity and overweight while incorporating new drugs like GLP-1 agonists into comprehensive treatment plans.